Navidea to Present at Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Wall St futures steady with focus on Mideast talks, US-China summit
- Activist Jana Partners calls for Six Flags sale - WSJ
- Oil holds near two-week lows while diesel cracks hit record peak
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
Navidea Biopharma (NAVB) Shares Tick Higher on Positive CHMP Opinion for Lymphoseek
September 16, 2016 8:20 AM EDTNavidea Biopharma (NYSE: NAVB) shares are markedly higher amid a positive CHMP opinion on Lymphoseek issued this week. The stock is up nearly 9 percent in premarket trading.
For more color, click here.
... More